Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-10-28 16:15:09
Reporting Period:
Accepted Time:
2020-10-28 16:15:09
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1659323 Iterum Therapeutics Plc ITRM () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553593 W. Michael Dunne C/o Iterum Therapeutics Plc, Blk 2
Fl. 3, Harcourt Centre, Harcourt St.
Dublin L2 2
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-10-27 61,540 $0.00 209,498 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Warrants (right to buy) Acquisiton 2020-10-27 46,155 $0.00 46,155 $0.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,155 2020-10-27 2025-10-27 No 4 P Direct
  1. The reported securities were purchased in the Issuer's registered public offering on October 27, 2020 at a combined purchase price of $0.65 per ordinary share and warrant. Each ordinary share was purchased together with a warrant to purchase 0.75 of an ordinary share.